Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/182463
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bonilla, Lorena | - |
dc.contributor.author | Espina García, Marta | - |
dc.contributor.author | Severino, Patrícia | - |
dc.contributor.author | Cano Fernández, Amanda | - |
dc.contributor.author | Ettcheto Arriola, Miren | - |
dc.contributor.author | Camins Espuny, Antoni | - |
dc.contributor.author | García López, María Luisa | - |
dc.contributor.author | Souto, Eliana B. | - |
dc.contributor.author | Sánchez-López, E. (Elena) | - |
dc.date.accessioned | 2022-01-19T10:35:23Z | - |
dc.date.available | 2022-01-19T10:35:23Z | - |
dc.date.issued | 2022-01-01 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | http://hdl.handle.net/2445/182463 | - |
dc.description.abstract | This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, or Lipid Drug Conjugates) as effective drug carriers for pathologies affecting the posterior ocular segment. Eye anatomy and the most relevant diseases affecting the posterior segment will be summarized. Moreover, preparation methods and different types and subtypes of lipid nanoparticles will also be reviewed. Lipid nanoparticles used as carriers to deliver drugs to the posterior eye segment as well as their administration routes, pharmaceutical forms and ocular distribution will be discussed emphasizing the different targeting strategies most recently employed for ocular drug delivery | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics14010090 | - |
dc.relation.ispartof | Pharmaceutics, 2022, vol. 14, num. 1, p. 90 | - |
dc.relation.uri | https://doi.org/10.3390/pharmaceutics14010090 | - |
dc.rights | cc-by (c) Bonilla, Lorena et al., 2022 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
dc.subject.classification | Administració de medicaments | - |
dc.subject.classification | Farmacologia ocular | - |
dc.subject.classification | Sistemes d'alliberament de medicaments | - |
dc.subject.classification | Nanopartícules | - |
dc.subject.other | Administration of drugs | - |
dc.subject.other | Ocular pharmacology | - |
dc.subject.other | Drug delivery systems | - |
dc.subject.other | Nanoparticles | - |
dc.title | Lipid Nanoparticles for the Posterior Eye Segment | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 717463 | - |
dc.date.updated | 2022-01-19T10:35:24Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
717463.pdf | 3.23 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License